Avantor Inc.

Avantor, Inc. is a provider of mission critical products and services to customers in the biopharma, healthcare, education and government, and advanced technologies and applied materials industries. It sells materials, equipment, instrumentation, and offers specialty procurement. The firm operates through the following segments: the Americas, Europe, and AMEA. The company was founded by John Townsend Baker in 1904 and is headquartered in Radnor, PA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Avantor meets Q4 expectations, eyes bioproduction growth in 2023

Avantor delivered solid financial performance in Q4 and exceeded full-year revenue targets.
The company's focus on operational enhancements and global expansion supports future growth.
Challenges in the first quarter are being addressed with a focus on productivity and cost management.
Opportunities in bioproduction growth, M&A, and working capital improvements position Avantor for success.

Avantor Inc. reports Q1 revenue decline, eyes semiconductor market rebound

Avantor Inc. navigated challenges in Q1 with revenue declines due to destocking and semiconductor downturn, while showcasing strengths in innovation and acquisitions performance.
Management's confidence in the long-term strategy and focus on margin improvement present opportunities for growth and recovery in 2023, despite ongoing market challenges.
Strategic approaches to address destocking headwinds and market dynamics in different regions position Avantor Inc. for potential growth and resilience in the coming quarters.
Overall, Avantor Inc. faces challenges from market uncertainties but remains poised to leverage opportunities for growth, innovation, and margin improvement in the evolving landscape.

Avantor Inc. reports Q2 revenue decline, focuses on cost controls

Avantor Inc. faced revenue and EPS cuts in Q2 2023, driven by market challenges in biopharma and semiconductors. The company focused on cost savings, debt reduction, and operational efficiency. Challenges included limited visibility in research space and mid- to high single-digit organic decline in bioproduction.

Avantor Inc. reports Q3 revenue contraction, eyes growth opportunities

Avantor Inc. navigated challenges in Q3 2023 with a focus on growth and operational improvements.
Management's cautious yet optimistic stance reflects a strategic approach to customer sentiment and inventory health.
Outlook for 2024 remains uncertain, but the company is positioned to capitalize on opportunities in key markets.
Analyst questions addressed various topics, highlighting the company's proactive engagement with stakeholders.

Avantor Inc. exceeds Q4 expectations, eyes cost savings and margin growth

Avantor Inc. delivered solid Q4 results, focusing on executing business model transformation and driving growth strategy. Despite challenges in market conditions and revenue decline, the company is optimistic about cost-saving initiatives and margin improvement opportunities.

Avantor Inc. reports Q1 revenue decline but optimistic on growth

Avantor Inc. delivered mixed performance in Q1 2024 with revenue decline but strong margin and debt reduction. Despite challenges in certain segments and regions, the company remains optimistic about growth opportunities in key markets and cost-saving initiatives.

Avantor reports solid Q2 earnings, eyes growth in Bioprocessing segment

Avantor Inc.'s Q2 2024 performance showcased solid revenue, margin improvement, and strong segmental growth. While facing challenges in organic revenue decline and segmental performance, the company's focus on cost transformation and positive outlook signal resilience and potential for growth. Avantor's opportunities lie in leveraging Bioprocessing momentum and cost-saving initiatives for sustained performance enhancement.

Avantor Inc. reports solid Q3 performance and accelerates growth strategies

Avantor's Q3 performance reflects resilience and strategic focus amidst market challenges, with notable achievements in revenue, margin, and divestiture.
The company's strengths in innovation, operational excellence, and market positioning position it well for long-term growth and profitability.
While facing challenges in certain segments and cost transformation, Avantor's opportunities in renewable energy, cash flow, and market growth are promising.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Avantor, Inc. is a life science tools company that engages in providing mission-critical products and services to the life sciences and advanced technology industries. Its portfolio includes biopharma, healthcare, education and government, as well as advanced technologies and applied materials industries. It sells materials, equipment, instrumentation, and offers specialty procurement. The company operates through the following geographical segments: the Americas, Europe, and AMEA. Avantor was founded by John Townsend Baker in 1904 and is headquartered in Radnor, PA.

RADNOR, Pa., Oct. 2, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced that it will release its financial results for...

Avantor® to Report Third Quarter Earnings and Host Earnings Call on Wednesday, October 28, 2020

RADNOR, Pa., Sept. 22, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced Frederic Vanderhaegen has been appointed...

Avantor® Appoints Frederic Vanderhaegen Executive Vice President, Americas and Europe

RADNOR, Pa., Sept. 1, 2020 /PRNewswire/ -- Avantor, Inc.

Avantor® to Present at the Morgan Stanley Virtual Healthcare Conference

RADNOR, Pa., Aug. 31, 2020 /PRNewswire/ -- Avantor, Inc.

Avantor® to Present at the 2020 Wells Fargo Virtual Healthcare Conference

Avantor (AVTR) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

Avantor (AVTR) in Focus: Stock Moves 5.6% Higher

RADNOR, Pa., Aug. 19, 2020 /PRNewswire/ -- Avantor, Inc.

Avantor® Announces Secondary Offering of 38,500,000 Shares of Common Stock

RADNOR, Pa., Aug. 10, 2020 /PRNewswire/ -- Avantor, Inc.

Avantor Announces Credit Rating Upgrade by S&P Global Ratings

Avantor, Inc. (AVTR) CEO Michael Stubblefield on Q2 2020 Results - Earnings Call Transcript

Cognizant Technology Solutions

Equinix

Hologic

Lam Research

PayPal

QUALCOMM

Teladoc

The last week of July is also the week that marks the peak of the earnings season.

8 Earnings Winners Seeing Major Analyst Upgrades for Even More Upside Ahead

Avantor, Inc. (AVTR) delivered earnings and revenue surprises of 35.71% and -0.53%, respectively, for the quarter ended June 2020.

Avantor, Inc. (AVTR) Beats Q2 Earnings Estimates

Shares of Avantor (NYSE:AVTR) rose 3.64% in after-market trading after the company reported Q2 results.

Avantor: Q2 Earnings Insights

RADNOR, Pa., July 29, 2020 /PRNewswire/ -- Avantor, Inc.

Avantor® Reports Second Quarter 2020 Results

Avantor (AVTR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Why Earnings Season Could Be Great for Avantor (AVTR)

Avantor, Inc. (AVTR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

Avantor, Inc. (AVTR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

RADNOR, Pa., July 7, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR) ("Avantor"), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced today the pricing of the previously...

Avantor® Announces Upsizing and Pricing of Offering of $2.0 Billion Equivalent of Senior Notes

RADNOR, Pa., July 7, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, provided preliminary unaudited revenue estimates for the...

Avantor® Announces Preliminary Second Quarter 2020 Unaudited Revenue

RADNOR, Pa., June 30, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced the expansion of the company's Bridgewater,...

Avantor® Expands Life Sciences Innovation Center to Address Bioprocessing Needs in Protein Science, Monoclonal Antibodies (mAbs), Cell and Gene Therapy

Assurant

Blueprint Medicines

Boston Scientific

Cigna

Fortive

aTyr Pharma

Visa

Andreas Halvorsen (Trades, Portfolio)’s Viking Global Investors bought shares of the following stocks in both the fourth quarter of 2019 and the first quarter of 2020.

8 Stocks Viking Global Investors Continues to Buy

RADNOR, Pa., May 26, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR) ("Avantor" or the "Company"), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, today announced the closing of...

Avantor® Announces Closing of Secondary Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Adobe

Crown Hlds

DuPont de Nemours

FleetCor Technologies

Frontdoor Inc.

Nektar Therapeutics

Lee Ainslie (Trades, Portfolio)’s Maverick Capital bought shares of the following stocks in both the fourth quarter of 2019 and the first quarter of 2020.

7 Stocks Maverick Capital Continues to Buy

Avantor (AVTR) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.

Avantor (AVTR) Catches Eye: Stock Jumps 7.8%

RADNOR, Pa., May 22, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR) ("Avantor" or the "Company"), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, today announced that Fitch...

Avantor Announces Credit Rating Upgrade by Fitch Ratings

RADNOR, Pa., May 20, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR) ("Avantor" or the "Company"), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, today announced the pricing of...

Avantor® Announces Pricing of Secondary Offering

RADNOR, Pa., May 18, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR) ("Avantor" or the "Company"), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, today announced that certain...

Avantor® Announces Secondary Offering of 45,000,000 Shares of Common Stock

Sales growth was slow -- but look at that free cash flow number!

News for Avantor Inc. Stock (AVTR)